Provided by Tiger Fintech (Singapore) Pte. Ltd.

Acumen Pharmaceuticals, Inc.

0.9008
-0.0792-8.08%
Post-market: 0.90080.00000.00%19:59 EDT
Volume:487.31K
Turnover:446.65K
Market Cap:54.56M
PE:-0.53
High:1.02
Open:0.9800
Low:0.8686
Close:0.9800
Loading ...
Mar 27, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Mar 27, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 27, 2025

Major Issues Report

Form 8-K - Current report
Jan 23, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 21, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 21, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 21, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 21, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 21, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 03, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 03, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 03, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 03, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jan 03, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 13, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 12, 2024

Major Issues Report

Form 8-K - Current report
Aug 13, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 13, 2024

Major Issues Report

Form 8-K - Current report
Jun 05, 2024

Major Issues Report

Form 8-K - Current report
May 14, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]